Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bindlysh Biotec Limited is an Indian pharmaceutical company headquartered in Delhi, established in 1997. The company specializes in the manufacture and supply of a diverse range of pharmaceutical products, medicinal chemicals, and botanical substances. Its portfolio includes various therapeutic categories such as anti-infectives, analgesics, and gastrointestinal treatments, marketed under brands like Aceclocare, Nimulis, and Azicare. As a public unlisted entity, Bindlysh Biotec focuses on the production of bulk drugs and pharmaceutical raw materials for both domestic and international markets. The company maintains an active presence in the manufacturing sector with a long-standing history of over 25 years in the industry. It operates primarily from its facility in the Jhilmil Industrial Area of New Delhi.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bindlysh Biotech.